Talk Track 3 - Clinical Development (CD) track
India as a Biopharma Hub for Global Clinical Development
Wed, Nov 18, 2026 · 11:30 AM–1:00 PM IST Multipurpose Hall (Second Floor), CIDCO Auditorium & Convention Centre
About this session
Session Overview : GCCs & India as Innovation Hub; UP-IMRAS initiatives; Patient advocacy Programme: CD.S1.T1: Strategic Vision: India as a Global Biopharma Hub by 2030; CD.S1.T2: India's Clinical Trial Advantage: What Will It Take to Compete Globally?; CD.S1.T3: Panel Discussion: Is India Ready to Become a Preferred Destination for Global Clinical Trials?.
Speakers
-
Head India R&D Operations · IQVIA
Chair
-
Senior Director - India / South-East Asia Cluster, GSSO, Clinical Development & Operations, R&D · Pfizer
Speaker
-
General Manager (Head - Global Clinical Quality Control and Operational Excellence) · SUN PHARMA
Speaker
-
Professor, Department of Pharmacology · DY Patil School of Medicine, Navi Mumbai
Speaker
